Sumitomo Dainippon Pharma

15.72 <%= Resources.Global.txtDown %>
Updated 15:02:38
Change % -0.27% Stock price decreasing
Change -0.042 Stock price decreasing
Volume 0
High 15.72
Low 15.72
Open 15.72
ISIN JP3495000006
Prev close 15.76
# of shares 397.90M
Market cap 6,254.99M EUR

Sumitomo Dainippon Pharma
Market is open (until 19:00) - Delayed 15 min
Price development Latest 1 week 1 month 3 months 6 months 1 year
  15.72 2.5% Stock price increasing 0.3% Stock price increasing -5.7% Stock price decreasing -26.6% Stock price decreasing -11.8% Stock price decreasing
Powered by TradingView

Company profile

Sumitomo Dainippon Pharma Co is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
18 September 2019 15:24:29
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190829.2 - EUROWEB3 - 2019-09-18 16:24:29 - 2019-09-18 15:24:29 - 1000 - Website: OKAY